Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model
出版年份 2015 全文链接
标题
Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model
作者
关键词
-
出版物
NEUROPSYCHOPHARMACOLOGY
Volume 41, Issue 2, Pages 598-610
出版商
Springer Nature
发表日期
2015-06-25
DOI
10.1038/npp.2015.189
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction
- (2015) Adam G. Walker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Early Adolescent MK-801 Exposure Impairs the Maturation of Ventral Hippocampal Control of Basolateral Amygdala Drive in the Adult Prefrontal Cortex
- (2014) D. R. Thomases et al. JOURNAL OF NEUROSCIENCE
- Direct excitation of parvalbumin-positive interneurons by M1muscarinic acetylcholine receptors: roles in cellular excitability, inhibitory transmission and cognition
- (2014) Feng Yi et al. JOURNAL OF PHYSIOLOGY-LONDON
- Role of PFC during retrieval of recognition memory in rodents
- (2014) Pedro Bekinschtein et al. JOURNAL OF PHYSIOLOGY-PARIS
- Smoking Restores Impaired LTD-Like Plasticity in Schizophrenia: a Transcranial Direct Current Stimulation Study
- (2014) Wolfgang Strube et al. NEUROPSYCHOPHARMACOLOGY
- Antipsychotic Drug-Like Effects of the Selective M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator VU0152100
- (2014) Nellie E Byun et al. NEUROPSYCHOPHARMACOLOGY
- Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers
- (2014) Tanja Veselinović et al. PSYCHOPHARMACOLOGY
- Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: A translational link to humans
- (2013) Joanna C. Neill et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Enhanced prefrontal serotonin 2A receptor signaling in the subchronic phencyclidine mouse model of schizophrenia
- (2013) Martin A. Santini et al. JOURNAL OF NEUROSCIENCE RESEARCH
- The role of the hippocampo-prefrontal cortex system in phencyclidine-induced psychosis: A model for schizophrenia
- (2013) Eiichi Jodo JOURNAL OF PHYSIOLOGY-PARIS
- Prefrontal Cortex Activity during Response Selection Predicts Processing Speed Impairment in Schizophrenia
- (2013) Neil D. Woodward et al. JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
- Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA
- (2013) E Scarr et al. Translational Psychiatry
- Reduced Medial Prefrontal Responses to Social Interaction Images in Remitted Depression
- (2012) Rebecca Elliott ARCHIVES OF GENERAL PSYCHIATRY
- Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia
- (2012) Andrew Stuart Gibbons et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Novel Allosteric Agonists of M1 Muscarinic Acetylcholine Receptors Induce Brain Region-Specific Responses That Correspond with Behavioral Effects in Animal Models
- (2012) G. J. Digby et al. JOURNAL OF NEUROSCIENCE
- NMDA receptor blockade impairs the muscarinic conversion of sub-threshold transient depression into long-lasting LTD in the hippocampus–prefrontal cortex pathway in vivo: Correlation with gamma oscillations
- (2012) Cleiton Lopes-Aguiar et al. NEUROPHARMACOLOGY
- Isolation rearing attenuates social interaction-induced expression of immediate early gene protein products in the medial prefrontal cortex of male and female rats
- (2012) Vanessa L. Wall et al. PHYSIOLOGY & BEHAVIOR
- The M1/M4 preferring agonist xanomeline reverses amphetamine-, MK801- and scopolamine-induced abnormalities of latent inhibition: putative efficacy against positive, negative and cognitive symptoms in schizophrenia
- (2011) Segev Barak et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Induction of Activity-Dependent LTD Requires Muscarinic Receptor Activation in Medial Prefrontal Cortex
- (2011) D. A. Caruana et al. JOURNAL OF NEUROSCIENCE
- mGluR and NMDAR activation internalize distinct populations of AMPARs
- (2011) Tanya M. Casimiro et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Selective Blockade of Dopamine D3 Receptors Enhances while D2 Receptor Antagonism Impairs Social Novelty Discrimination and Novel Object Recognition in Rats: A Key Role for the Prefrontal Cortex
- (2011) David JG Watson et al. NEUROPSYCHOPHARMACOLOGY
- Mechanisms underlying ketamine-induced synaptic depression in rat hippocampus-medial prefrontal cortex pathway
- (2010) H. Kamiyama et al. NEUROSCIENCE
- Animal models of cognitive dysfunction and negative symptoms of schizophrenia: Focus on NMDA receptor antagonism
- (2010) Joanna C. Neill et al. PHARMACOLOGY & THERAPEUTICS
- Identification of the Hippocampal Input to Medial Prefrontal Cortex In Vitro
- (2009) M. A. Parent et al. CEREBRAL CORTEX
- Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: A possible role of α1-adrenoceptors
- (2009) Yuko Tanibuchi et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A Selective Allosteric Potentiator of the M1 Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal Learning
- (2009) J. K. Shirey et al. JOURNAL OF NEUROSCIENCE
- Activation of M2 muscarinic receptors leads to sustained suppression of hippocampal transmission in the medial prefrontal cortex
- (2009) Lang Wang et al. JOURNAL OF PHYSIOLOGY-LONDON
- A Novel Selective Muscarinic Acetylcholine Receptor Subtype 1 Antagonist Reduces Seizures without Impairing Hippocampus-Dependent Learning
- (2009) D. J. Sheffler et al. MOLECULAR PHARMACOLOGY
- Effects of subchronic phencyclidine (PCP) treatment on social behaviors and operant discrimination and reversal learning in C57BL/6J mice
- (2009) Jonathan L. Brigman Frontiers in Behavioral Neuroscience
- Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia
- (2008) Anantha Shekhar et al. AMERICAN JOURNAL OF PSYCHIATRY
- Role of the cholinergic system in the pathology and treatment of schizophrenia
- (2008) Elizabeth Scarr et al. Expert Review of Neurotherapeutics
- Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia
- (2008) E Scarr et al. MOLECULAR PSYCHIATRY
- Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia
- (2008) W. Y. Chan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phencyclidine-Induced Cognitive Deficits in Mice Are Improved by Subsequent Subchronic Administration of the Novel Selective α7 Nicotinic Receptor Agonist SSR180711
- (2007) Kenji Hashimoto et al. BIOLOGICAL PSYCHIATRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started